Phosphorylation of mTOR is considered a marker of tumour progression and mediates the activation of downstream targets such as S6K and 4E-BP1, the activation of which leads to an increased risk of tumor development and poor prognosis (Rascio et al., 2021). This evidence concerns the gene RPS6KB1 and neoplasm.